stopOverflowHandler
NEW PHARMACEUTICAL COMPOUNDS FOR TREATING MALARIA
Principal Investigator: Laurent Meijer

 

CONTEXT

Malaria is responsible each year for 250-300 million clinical cases leading to 1 to 3 millions deaths. Plasmodium falciparum is the parasite of malaria that causes most deaths but other species such as P. vivax, P. malariae, P. ovale, P. knowlesi contribute to malaria in various areas. P. falciparum is the most dangerous of these infections as P. falciparum malaria has the highest rates of complications and mortality. Due to worldwide increasing resistance of Plasmodium falciparum against drugs, there is a real need to develop new chemical structures with new biological pathways.


To read more, please register or connect in the right pannel...
 
< Prev   Next >
 
 

Identification






Direct Access
+33 1 40 51 00 90
FIST SA dans Les Echos

Les IP Overviews dans Les ...
Details ...



Concours de création d’entreprises de biotechnologie

Genopole® lance un concours de création d’entreprises destiné aux étudiants, aux chercheurs, aux ...
Details ...



Les IP Overviews dans lifepo4-info

2010 Report on Lithium Metal Phosphate Patent ...
Details ...



 
   
viagra 100mg